Related Experiment Video
Updated: Jan 26, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Occupational class differences in pancreatic cancer survival: A population-based cancer registry-based study in Japan
Masayoshi Zaitsu1,2, Yongjoo Kim2, Hye-Eun Lee2,3
1Department of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Background:
Little is known about occupational class differences in pancreatic cancer survival.
Methods:
Using a population-based cancer registry in Japan, 3 578 patients with incident pancreatic cancer (1970-2011) were followed up for 5 years (median follow-up time 0.42 years). We classified patients into four occupational classes based on their longest-held jobs: white-collar (professional and managers), service, blue-collar, and those not actively employed. Using white-collar class as the reference group, hazard ratios (HRs) and 95% confidence intervals (CIs) for overall death were estimated by Cox proportional hazard model. Covariates included age, sex, and year of diagnosis. Prognostic variables (pathology, stage, and treatment) and smoking behaviors were additionally adjusted as possible mediating factors.
Results:
Overall survival was poor in this population (median, 0.50 and 0.33 years in white-collar and service classes, respectively). Compared with white-collar patients, survival was significantly poorer across all occupational classes, most pronounced in the service worker group: mortality HRs ranged from 1.11 (95% CI 1.00-1.24) in blue-collar workers to 1.24 (95% CI 1.12-1.37) in service workers. Even after controlling for potential mediating factors, service workers showed worse survival.
Conclusion:
We documented occupational class disparities in pancreatic cancer survival in Japan. Even in the setting of lethal prognostic cancer with universal health coverage, high-occupational class groups may enjoy a health advantage.
Related Concept Videos
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

